ASCO Guidelines

An interview with Dr. Nancy E. Davidson from Fred Hutchinson Cancer Research Center and University of Washington on the guideline update which provides recommendations on systemic therapy for patients with human epidermal growth factor receptor 2 (HER2)–positive advanced breast cancer. Read the full guideline at www.asco.org/breast-cancer-guidelines

An interview with Dr. Gary Lyman from Fred Hutchinson Cancer Research Center and University of Washington and Dr. Lorenzo Cohen from the University of Texas MD Anderson Cancer Center on the ASCO endorsement of the SIO guideline on use of integrative therapies during and after breast cancer treatment. The guideline addresses the use of integrative therapies for the management of symptoms and adverse effects. Read the full guideline at www.asco.org/supportive-care-guidelines.

An interview with Dr. Hedy Kindler of the University of Chicago on the guideline which includes recommendations on diagnosis, staging, chemotherapy, surgical cytoreduction, radiation therapy, and multimodality therapy in patients with malignant pleural mesothelioma. Read the full guideline at www.asco.org/thoracic-cancer-guidelines

An interview with Dr. Antonio Wolff from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center on the ASCO/CAP guideline update which addresses IHC and ISH testing for HER2 in breast cancer. Read the full guideline at www.asco.org/breast-cancer-guidelines

An interview with Dr. Davendra Sohal from the Cleveland Clinic on the guideline update regarding second-line therapy for patients with metastatic pancreatic cancer. Read the full guideline at www.asco.org/gastrointestinal-cancer-guidelines

An interview with Dr. Neelima Denduluri from US Oncology, Virginia Cancer Specialists, on the key recommendations of the ASCO guideline adaptation of the Cancer Care Ontario guideline on the selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for breast cancer. Read the full guideline on www.asco.org/breast-cancer-guidelines

An interview with Dr. Supriya Mohile from University of Rochester on the guideline published in JCO which provides guidance regarding the practical assessment and management of vulnerabilities in older patients undergoing chemotherapy. To read the full guideline go to www.asco.org/supportive-care-guidelines.

An interview with Dr. Neelima Denduluri, Dr. Manish Shah, Dr. Mariana Chavez Mac Gregor, and Tom Oliver discussing the ASCO Clinical Practice Guidelines program, methodology, panel representation, and vision for the future. Read more at www.asco.org/guidelines

An interview with Dr. Nahla Gafer from Radiation & Isotope Center in Sudan on the Palliative Care in the Global Setting: ASCO Resource-Stratified Guideline. The purpose of this new resource-stratified guideline is to provide expert guidance to clinicians and policymakers on implementing palliative care in resource-constrained settings and is intended to complement the Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Update of 2016. It is the view of the ASCO that health care providers and health care system decision makers should be guided by the recommendations for the highest stratum of resources available. The guideline is intended to complement but not replace local guidelines. Read the full guideline at www.asco.org/resource-stratified-guidelines

An interview with Dr. Paul Hesketh from Lahey Hospital and Medical Center on the antiemetics guideline update published in 2017. The guideline update expands the recommendations to include olanzapine and neurokinin 1 receptor antagonists. Read the full guideline at www.asco.org/supportive-care-guidelines